Ginny Blocki serves as the SVP, Strategy for embecta, where she is accountable for developing the company’s strategy, partnership and alliance growth initiatives, seeking new avenues to drive embecta’s future growth and assessing new business development opportunities. She joined the organization in 2021 as SVP, Global Marketing & Product Management. Prior to embecta, Ginny was with Baxter as the Head of US Medication Delivery Marketing. Prior to her role at Baxter, Ginny was the Vice President Specialty Products with Assertio Therapeutics, where she played a key role in product development of a priority asset and multiple business development endeavors while leading marketing and sales efforts.

Before joining Assertio, Ginny served as Head of Global Marketing Molecular Diagnostics at Abbott Laboratories, overseeing and leading all commercial activities. Prior to Abbott, Ginny served as the Vice President, Head of Global Marketing Immunology with Baxter and Baxalta (spin off from Baxter) where she played a vital role in the Global Immunology business. Throughout her career, Ginny has held leadership roles of increasing responsibility in general management, marketing, strategy, market access, and sales. She has a proven track record for transforming businesses, developing successful portfolios and brands through all phases of product development, and leading cross-functional teams on a regional, national, and global scale. Ginny is passionate about helping patients achieve better health outcomes and driving sustainable business growth, with a focus on building high-performing teams and capabilities that will outpace the complex global healthcare landscape.

Ginny holds a Bachelor of Science degree in finance from Indiana University. She’s also a Kellogg School of Management alum having completed the Executive Scholar Program in General Management.